Barclays 2011 Annual Report Download - page 65

Group Chairman and non-executive Directors
The Group Chairman and the non-executive Directors receive fees which
reflect individual responsibilities and membership of Board Committees.
Fees are reviewed each year by the Board and for non-executive Directors
were increased with effect from 1 May 2011. Prior to that, non-executive
Director fees were last increased in June 2008. The Group Chairman's fees
have not changed since his appointment.
The first £30,000 (2010: first £20,000) of the non-executive Directors'
base fees is used to purchase Barclays shares which are retained on the
non-executive Directors' behalf until they retire from the Board.
The Group Chairman has a minimum time commitment to Barclays
equivalent to 60% of a full-time role. In addition to his fees he receives
private medical insurance and he is provided with the use of a company
vehicle and company driver when required for business purposes. The
Group Chairman is not eligible to receive a bonus, nor to participate in
Barclays cash, share or long term incentive plans. The Group Chairman
does not participate in Barclays pension plans and he does not receive any
pension contributions. No other non-executive Director receives any
benefits from Barclays.
Membership and Chairmanship of Board Committees as at 31 December
2011 and details of the fees received during 2011 are set out in Table 19.
Details of beneficial interests in Barclays shares are set out in Table 20.
Table 19: 2011 fees for the Group Chairman and non-executive Directors (audited)
Chairman
£000
Senior
Independent
Director
£000
Board
Member
£000
Board
Audit
Committee
£000
Board
Remuneration
Committee
£000
Board
Corporate
Governance
and
Nominations
Committee
£000
Board
Citizenship
Committee
£000
Board Risk
Committee
£000
Benefits
£000
Total
2011
£000
Total
2010
£000
Fees at 31 December 2011
Full-year fee 750 30 80 – – – – – – ––
Committee Chair –––7070––60–––
Committee Member – ––30 30 151525–––
Fees to 31 December 2011
Group Chairman
Marcus Agius Ch. – – – M. Ch. Ch. – 1 751 751
Non-executive Directors
David Booth – – M. – – M. – Ch. – 145 125
Alison Carnwath – – M. M. Ch. M. – – – 158 39
Fulvio Conti ––M.M.–––––105 95
Simon Fraser – – M. M. M. – – – – 130 110
Reuben Jeffery III ––M.––––M.–98 85
Sir Andrew Likierman ––M.M.–––M.–127 110
Dambisa Moyo – – M. – – – M. M. – 105 50
Sir Michael Rake – SID. M. Ch. – M. – M. – 188 160
Sir John Sunderland – –M.–M.M.M.––132 115
Sir Richard Broadbent –––––––––171 200
Note to Table 19: Alison Carnwath became Chairman of the Board Remuneration Committee and a member of the Board Corporate Governance and Nominations Committee on 1 July 2011.
Dambisa Moyo and Sir John Sunderland became members of the Board Citizenship Committee on 1 August 2011. Sir Michael Rake became Senior Independent Director on 1 October 2011.
Sir Richard Broadbent resigned as a non-executive Director with effect from 30 September 2011.
Table 20: Interests in Barclays PLC shares
At
1 January
2011
total
beneficial
interests
At
31 December
2011
total
beneficial
interests
At
2 March
2012
total
beneficial
interests
Group Chairman
Marcus Agius 115,129 232,244 232,244
Non-executive Directors
David Booth 77,285 82,867 86,806
Alison Carnwath 40,000 44,738 47,742
Fulvio Conti 42,970 48,500 52,455
Simon Fraser 49,768 79,514 83,144
Reuben Jeffery III 65,244 72,174 77,183
Sir Andrew Likierman 27,031 32,329 35,686
Dambisa Moyo 2,826 7,798 11,429
Sir Michael Rake 18,954 35,213 38,378
Sir John Sunderland 83,277 88,058 91,187
Note to Table 20: Reuben Jeffery's beneficial interest as at 31 December 2011 comprised
15,000 American Depositary Shares and 12,174 Barclays PLC shares, and as at 2 March 2012
comprised 15,000 American Depositary Shares and 17,183 Barclays PLC shares. Except as
described in this note, there were no changes to the total beneficial interests of the
non-executive Directors in the period from 31 December 2011 to 2 March 2012.
Barclays PLC Annual Report 2011 www.barclays.com/annualreport 63
The strategic report Governance Risk management Financial review Financial statements Shareholder information